Sonja Strang-Karlsson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Sonja Strang-Karlsson has a total of 113 co-authors. Here are the top co-authors by number of shared publications:
Eero Kajantie
Finnish Institute for Health and Welfare, Helsinki, Finland
5 shared publicationsPetteri Hovi
Finnish Institute for Health and Welfare, Helsinki, Finland
5 shared publications- Anu-Katriina Pesonen
SleepWell Research Program, Faculty of Medicine, University of Helsinki, Finland
4 shared publications - Johan Gunnar Eriksson
Department of General Practice and Primary Health Care, University of Helsinki, Helsinki, Finland
4 shared publications - Kati Heinonen
University of Helsinki, Finland
4 shared publications Sture Andersson
Institute of Clinical Medicine, Children's Hospital, Helsinki University Central Hospital and University of Helsinki, Helsinki, Finland
4 shared publications
Latest Publications
- Open Access
The Nordic ChiCaP Network: An interdisciplinary approach to childhood cancer predisposition
- Open Access
- 1 January 2025
- Published by SAGE Publications in Journal of Neuromuscular Diseases
- Vol. 12 (1) , 57-69
Nutritional status of patients with nemaline myopathy and related congenital myopathies in Finland: A pilot study
Background: The muscle weakness in patients with nemaline myopathy (NM) and related disorders (NMR) often affects the muscles used for eating and dining, and some scientific evidence of poorer nutritional status of patients with myopathy exists. However, comprehensive research on the nutritional status of persons with NM or NMR has not been done. Objectives: Our aim was to conduct a comprehensive cross-sectional pilot study among adult Finnish patients with NM or NMR to investigate their food consumption, nutrient intakes, selected nutrient-related laboratory parameters in blood, and self-assessed functioning of dining and eating and of the gastrointestinal tract. We also aimed to test the suitability of the methods selected. Methods: The methods included a questionnaire to investigate eating-related functioning, a food frequency questionnaire, food records, and laboratory analyses from blood samples. Results: Of 32 invited patients, 20 returned the survey and food frequency questionnaire. Food records were returned by 17, and blood samples were obtained from 16. Food consumption as well as nutrient and energy intake were highly variable between the individuals. Low energy intakes, low consumption of healthy foods, such as fruits, vegetables, and whole grains as well as low intakes of vitamin D, calcium, dietary fiber, vitamin C, folate, and iron were observed. Low nutrient intakes were seen especially in non-ambulatory participants, who also reported challenges in eating and dining related functioning. The laboratory parameters did not indicate severe undernourishment in any of the participants. Conclusions: Evaluation of food consumption and nutrient intakes were needed to find patients with risk of undernourishment. The results underline the importance of monitoring adequate intake of calcium and vitamin D in this group of patients, especially because of the immobility-induced risk of osteoporosis. Non-ambulatory patients reported more challenges in eating and dining. This, however, did not determine the nutritional status of the patient.
- 1 January 2025
- Published by SAGE Publications in Journal of Neuromuscular Diseases
- Vol. 12 (1) , 57-69
Open AccessNutritional status of patients with nemaline myopathy and related congenital myopathies in Finland: A pilot study
Background: The muscle weakness in patients with nemaline myopathy (NM) and related disorders (NMR) often affects the muscles used for eating and dining, and some scientific evidence of poorer nutritional status of patients with myopathy exists. However, comprehensive research on the nutritional status of persons with NM or NMR has not been done. Objectives: Our aim was to conduct a comprehensive cross-sectional pilot study among adult Finnish patients with NM or NMR to investigate their food consumption, nutrient intakes, selected nutrient-related laboratory parameters in blood, and self-assessed functioning of dining and eating and of the gastrointestinal tract. We also aimed to test the suitability of the methods selected. Methods: The methods included a questionnaire to investigate eating-related functioning, a food frequency questionnaire, food records, and laboratory analyses from blood samples. Results: Of 32 invited patients, 20 returned the survey and food frequency questionnaire. Food records were returned by 17, and blood samples were obtained from 16. Food consumption as well as nutrient and energy intake were highly variable between the individuals. Low energy intakes, low consumption of healthy foods, such as fruits, vegetables, and whole grains as well as low intakes of vitamin D, calcium, dietary fiber, vitamin C, folate, and iron were observed. Low nutrient intakes were seen especially in non-ambulatory participants, who also reported challenges in eating and dining related functioning. The laboratory parameters did not indicate severe undernourishment in any of the participants. Conclusions: Evaluation of food consumption and nutrient intakes were needed to find patients with risk of undernourishment. The results underline the importance of monitoring adequate intake of calcium and vitamin D in this group of patients, especially because of the immobility-induced risk of osteoporosis. Non-ambulatory patients reported more challenges in eating and dining. This, however, did not determine the nutritional status of the patient.
- Open Access
- 11 October 2022
- Published by Wiley in Clinical Case Reports
- Vol. 10 (10) , e6455
Multi‐exon COL5A1 deletion in a child with classical Ehlers–Danlos syndrome: A case report expanding the allelic spectrum and showing evidence of parental gonosomal mosaicism
Classical Ehlers–Danlos syndrome (cEDS) is a rare inherited autosomal dominant connective tissue disorder with core clinical features including skin hyperextensibility, abnormal scarring, and generalized joint hypermobility. Classical EDS is predominantly caused by small pathogenic variants in the genes COL5A1 and COL5A2 and occasionally by a COL1A1 point mutation p.(Arg312Cys), while gross deletions or duplications are uncommon. Gonosomal mosaicism is thought to be exceedingly rare with only two cases reported in the literature. We report a child with cEDS due to a rare gross deletion of exons 2–65 in the COL5A1 gene, inherited from an unaffected mosaic father. The level of mosaicism in the father was approximately 43% in leucocyte cells and 30% in DNA extracted from skin. Our results expand the allelic spectrum of cEDS variants and suggest that parental mosaicism needs to be considered in patients with suspected cEDS, given its implication for genetic counseling.
- 11 October 2022
- Published by Wiley in Clinical Case Reports
- Vol. 10 (10) , e6455
Open AccessMulti‐exon COL5A1 deletion in a child with classical Ehlers–Danlos syndrome: A case report expanding the allelic spectrum and showing evidence of parental gonosomal mosaicism
Classical Ehlers–Danlos syndrome (cEDS) is a rare inherited autosomal dominant connective tissue disorder with core clinical features including skin hyperextensibility, abnormal scarring, and generalized joint hypermobility. Classical EDS is predominantly caused by small pathogenic variants in the genes COL5A1 and COL5A2 and occasionally by a COL1A1 point mutation p.(Arg312Cys), while gross deletions or duplications are uncommon. Gonosomal mosaicism is thought to be exceedingly rare with only two cases reported in the literature. We report a child with cEDS due to a rare gross deletion of exons 2–65 in the COL5A1 gene, inherited from an unaffected mosaic father. The level of mosaicism in the father was approximately 43% in leucocyte cells and 30% in DNA extracted from skin. Our results expand the allelic spectrum of cEDS variants and suggest that parental mosaicism needs to be considered in patients with suspected cEDS, given its implication for genetic counseling.
- Open Access
- 17 March 2021
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 185 (6) , 1875-1882
A novel MPLKIP‐variant in three Finnish patients with non‐photosensitive trichothiodystrophy type 4
Trichothiodystrophy is a group of multisystem neuroectodermal disorders with dysplastic hair as the cardinal symptom. We describe three patients from two Finnish families in whom whole‐exome sequencing revealed a novel homozygous variant, c.26del, p.(Pro9Glnfs*144) in the MPLKIP‐gene, confirming the diagnosis of non‐photosensitive trichothiodystrophy type 4 (TTD4). The variant was confirmed by Sanger sequencing and inherited from unaffected carrier parents. This report adds to the literature by expanding the genetic and phenotypic spectra of MPLKIP‐related trichothiodystrophy. We describe dysmorphic features in the patients and provide a comparison of clinical characteristics in patients with TTD4 reported to date.
- 17 March 2021
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 185 (6) , 1875-1882
Open AccessA novel MPLKIP‐variant in three Finnish patients with non‐photosensitive trichothiodystrophy type 4
Trichothiodystrophy is a group of multisystem neuroectodermal disorders with dysplastic hair as the cardinal symptom. We describe three patients from two Finnish families in whom whole‐exome sequencing revealed a novel homozygous variant, c.26del, p.(Pro9Glnfs*144) in the MPLKIP‐gene, confirming the diagnosis of non‐photosensitive trichothiodystrophy type 4 (TTD4). The variant was confirmed by Sanger sequencing and inherited from unaffected carrier parents. This report adds to the literature by expanding the genetic and phenotypic spectra of MPLKIP‐related trichothiodystrophy. We describe dysmorphic features in the patients and provide a comparison of clinical characteristics in patients with TTD4 reported to date.
- 9 December 2020
- Published by SAGE Publications in Cephalalgia
- Vol. 41 (6) , 677-689
Migraine in children and adults born preterm: A nationwide register linkage study
Objective: Being born preterm is related to adverse health effects later in life. We studied whether preterm birth predicts the risk of migraine. Methods: In this nationwide register study, we linked data from six administrative registers for all 235,624 children live-born in Finland (January 1987 to September 1990) and recorded in the Finnish Medical Birth Register. n = 228,610 (97.0%) had adequate data and were included. Migraine served as primary outcome variable and was stringently defined as a diagnosis from specialised health care and/or ≥2 reimbursed purchases of triptans. We applied sex- and birth year-stratified Cox proportional hazard regression models to compute hazard ratios and confidence intervals (95% confidence intervals) for the association between preterm categories and migraine. The cohort was followed up until an average age of 25.1 years (range: 23.3–27.0). Results: Among individuals born extremely preterm (23–27 completed weeks of gestation), the adjusted hazard ratios for migraine was 0.55 (0.25–1.24) when compared with the full-term reference group (39–41 weeks). The corresponding adjusted hazard ratios and 95% confidence intervals for the other preterm categories were: Very preterm (28–31 weeks); 0.95 (0.68–1.31), moderately preterm (32–33 weeks); 0.96 (0.73–1.27), late preterm (34–36 weeks); 1.01 (0.91–1.11), early term (37–38 weeks); 0.98 (0.93–1.03), and post term (42 weeks); 0.98 (0.89–1.08). Migraine was predicted by parental migraine, lower socioeconomic position, maternal hypertensive disorder and maternal smoking during pregnancy. Conclusion: We found no evidence for a higher risk of migraine among individuals born preterm.
- 9 December 2020
- Published by SAGE Publications in Cephalalgia
- Vol. 41 (6) , 677-689
Migraine in children and adults born preterm: A nationwide register linkage study
Objective: Being born preterm is related to adverse health effects later in life. We studied whether preterm birth predicts the risk of migraine. Methods: In this nationwide register study, we linked data from six administrative registers for all 235,624 children live-born in Finland (January 1987 to September 1990) and recorded in the Finnish Medical Birth Register. n = 228,610 (97.0%) had adequate data and were included. Migraine served as primary outcome variable and was stringently defined as a diagnosis from specialised health care and/or ≥2 reimbursed purchases of triptans. We applied sex- and birth year-stratified Cox proportional hazard regression models to compute hazard ratios and confidence intervals (95% confidence intervals) for the association between preterm categories and migraine. The cohort was followed up until an average age of 25.1 years (range: 23.3–27.0). Results: Among individuals born extremely preterm (23–27 completed weeks of gestation), the adjusted hazard ratios for migraine was 0.55 (0.25–1.24) when compared with the full-term reference group (39–41 weeks). The corresponding adjusted hazard ratios and 95% confidence intervals for the other preterm categories were: Very preterm (28–31 weeks); 0.95 (0.68–1.31), moderately preterm (32–33 weeks); 0.96 (0.73–1.27), late preterm (34–36 weeks); 1.01 (0.91–1.11), early term (37–38 weeks); 0.98 (0.93–1.03), and post term (42 weeks); 0.98 (0.89–1.08). Migraine was predicted by parental migraine, lower socioeconomic position, maternal hypertensive disorder and maternal smoking during pregnancy. Conclusion: We found no evidence for a higher risk of migraine among individuals born preterm.
- Open Access
- 30 July 2018
- Published by Springer Nature in Skeletal Muscle
- Vol. 8 (1) , 1-12
Detection of variants in dystroglycanopathy-associated genes through the application of targeted whole-exome sequencing analysis to a large cohort of patients with unexplained limb-girdle muscle weakness
Dystroglycanopathies are a clinically and genetically heterogeneous group of disorders that are typically characterised by limb-girdle muscle weakness. Mutations in 18 different genes have been associated with dystroglycanopathies, the encoded proteins of which typically modulate the binding of α-dystroglycan to extracellular matrix ligands by altering its glycosylation. This results in a disruption of the structural integrity of the myocyte, ultimately leading to muscle degeneration. Deep phenotypic information was gathered using the PhenoTips online software for 1001 patients with unexplained limb-girdle muscle weakness from 43 different centres across 21 European and Middle Eastern countries. Whole-exome sequencing with at least 250 ng DNA was completed using an Illumina exome capture and a 38 Mb baited target. Genes known to be associated with dystroglycanopathies were analysed for disease-causing variants. Suspected pathogenic variants were detected in DPM3, ISPD, POMT1 and FKTN in one patient each, in POMK in two patients, in GMPPB in three patients, in FKRP in eight patients and in POMT2 in ten patients. This indicated a frequency of 2.7% for the disease group within the cohort of 1001 patients with unexplained limb-girdle muscle weakness. The phenotypes of the 27 patients were highly variable, yet with a fundamental presentation of proximal muscle weakness and elevated serum creatine kinase. Overall, we have identified 27 patients with suspected pathogenic variants in dystroglycanopathy-associated genes. We present evidence for the genetic and phenotypic diversity of the dystroglycanopathies as a disease group, while also highlighting the advantage of incorporating next-generation sequencing into the diagnostic pathway of rare diseases.
- 30 July 2018
- Published by Springer Nature in Skeletal Muscle
- Vol. 8 (1) , 1-12
Open AccessDetection of variants in dystroglycanopathy-associated genes through the application of targeted whole-exome sequencing analysis to a large cohort of patients with unexplained limb-girdle muscle weakness
Dystroglycanopathies are a clinically and genetically heterogeneous group of disorders that are typically characterised by limb-girdle muscle weakness. Mutations in 18 different genes have been associated with dystroglycanopathies, the encoded proteins of which typically modulate the binding of α-dystroglycan to extracellular matrix ligands by altering its glycosylation. This results in a disruption of the structural integrity of the myocyte, ultimately leading to muscle degeneration. Deep phenotypic information was gathered using the PhenoTips online software for 1001 patients with unexplained limb-girdle muscle weakness from 43 different centres across 21 European and Middle Eastern countries. Whole-exome sequencing with at least 250 ng DNA was completed using an Illumina exome capture and a 38 Mb baited target. Genes known to be associated with dystroglycanopathies were analysed for disease-causing variants. Suspected pathogenic variants were detected in DPM3, ISPD, POMT1 and FKTN in one patient each, in POMK in two patients, in GMPPB in three patients, in FKRP in eight patients and in POMT2 in ten patients. This indicated a frequency of 2.7% for the disease group within the cohort of 1001 patients with unexplained limb-girdle muscle weakness. The phenotypes of the 27 patients were highly variable, yet with a fundamental presentation of proximal muscle weakness and elevated serum creatine kinase. Overall, we have identified 27 patients with suspected pathogenic variants in dystroglycanopathy-associated genes. We present evidence for the genetic and phenotypic diversity of the dystroglycanopathies as a disease group, while also highlighting the advantage of incorporating next-generation sequencing into the diagnostic pathway of rare diseases.
- 15 May 2018
- Published by Elsevier in Neuromuscular Disorders
- Vol. 28 (7) , 614-618
A novel compound heterozygous mutation in the POMK gene causing limb-girdle muscular dystrophy-dystroglycanopathy in a sib pair
- 15 May 2018
- Published by Elsevier in Neuromuscular Disorders
- Vol. 28 (7) , 614-618
A novel compound heterozygous mutation in the POMK gene causing limb-girdle muscular dystrophy-dystroglycanopathy in a sib pair
- 25 October 2010
- Published by Taylor & Francis in Chronobiology International
- Vol. 27 (9-10) , 1829-1842
MORNINGNESS PROPENSITY IN YOUNG ADULTS BORN PREMATURELY: THE HELSINKI STUDY OF VERY LOW BIRTH WEIGHT ADULTS
The authors explored morningness-eveningness propensity in adults born prematurely at very low birth weight (VLBW; < 1500g) and in controls born at term. At age 21 to 29 yrs, 184 participants completed the Morningness-Eveningness Questionnaire (MEQ). Compared with controls, VLBW adults scored higher in morningness propensity (group difference: 2.8 scores, 95% confidence interval: 0.1 to 5.5; p = .042). This finding was confined to those VLBW adults whose birth weight was not small for gestational age, and remained similar when adjusting for age, sex, and working conditions. The finding is potentially important, since morningness is associated with beneficial health outcomes. (Author correspondence: sonja. strang@helsinki. fi )
- 25 October 2010
- Published by Taylor & Francis in Chronobiology International
- Vol. 27 (9-10) , 1829-1842
MORNINGNESS PROPENSITY IN YOUNG ADULTS BORN PREMATURELY: THE HELSINKI STUDY OF VERY LOW BIRTH WEIGHT ADULTS
The authors explored morningness-eveningness propensity in adults born prematurely at very low birth weight (VLBW; < 1500g) and in controls born at term. At age 21 to 29 yrs, 184 participants completed the Morningness-Eveningness Questionnaire (MEQ). Compared with controls, VLBW adults scored higher in morningness propensity (group difference: 2.8 scores, 95% confidence interval: 0.1 to 5.5; p = .042). This finding was confined to those VLBW adults whose birth weight was not small for gestational age, and remained similar when adjusting for age, sex, and working conditions. The finding is potentially important, since morningness is associated with beneficial health outcomes. (Author correspondence: sonja. strang@helsinki. fi )
- 1 January 2010
- Published by American Academy of Pediatrics (AAP) in Pediatrics
- Vol. 125 (1) , e74-e82
Slower Reaction Times and Impaired Learning in Young Adults With Birth Weight <1500 g
OBJECTIVE: Children with very low birth weight (VLBW; <1500 g) perform worse on cognitive tests than do children who are born at term. Whether this difference persists into adulthood has been little studied. We assessed core neurocognitive abilities (processing speed, working memory, attention, and learning capacity) in young adults with VLBW and in term-born control subjects.
- 1 January 2010
- Published by American Academy of Pediatrics (AAP) in Pediatrics
- Vol. 125 (1) , e74-e82
Slower Reaction Times and Impaired Learning in Young Adults With Birth Weight <1500 g
OBJECTIVE: Children with very low birth weight (VLBW; <1500 g) perform worse on cognitive tests than do children who are born at term. Whether this difference persists into adulthood has been little studied. We assessed core neurocognitive abilities (processing speed, working memory, attention, and learning capacity) in young adults with VLBW and in term-born control subjects.
- 1 October 2008
- Published by American Psychiatric Association Publishing in American Journal of Psychiatry
- Vol. 165 (10) , 1345-1353
Very Low Birth Weight and Behavioral Symptoms of Attention Deficit Hyperactivity Disorder in Young Adulthood: The Helsinki Study of Very-Low-Birth-Weight Adults
Children with very low birth weight (<1500 g) are at increased risk for attention deficit hyperactivity disorder (ADHD). Whether this increased risk continues into adulthood is unknown. The authors assessed behavioral symptoms of ADHD in a well-characterized cohort of very-low-birth-weight young adults who were either small for gestational age (less than two standard deviations below the Finnish mean) or appropriate for gestational age (within two standard deviations of the mean). A total of 162 very-low-birth-weight subjects (small for gestational age: N=52; appropriate for gestational age: N=110) and 172 term comparison subjects 18 to 27 years of age completed the Adult Problem Questionnaire, which yielded six exploratory factor analysis-derived subscales. Participants were also asked about substance use. Very-low-birth-weight adults in the small for gestational age subgroup scored higher on the executive dysfunctioning and emotional instability subscales of the Adult Problem Questionnaire than did those in the appropriate for gestational age subgroup and the comparison group. The appropriate for gestational age and comparison groups had similar scores on these subscales. On the alcohol use subscale of the Adult Problem Questionnaire, both the appropriate and small for gestational age subgroups scored lower than comparison subjects and also reported fewer risk-taking behaviors (alcohol, smoking, and use of recreational drugs) than did comparison subjects. Rather than very low birth weight per se, intrauterine growth retardation, as reflected by small for gestational age status in the very-low-birth-weight subjects, confers a risk for behavioral and emotional adversity related to ADHD in young adulthood.
- 1 October 2008
- Published by American Psychiatric Association Publishing in American Journal of Psychiatry
- Vol. 165 (10) , 1345-1353
Very Low Birth Weight and Behavioral Symptoms of Attention Deficit Hyperactivity Disorder in Young Adulthood: The Helsinki Study of Very-Low-Birth-Weight Adults
Children with very low birth weight (<1500 g) are at increased risk for attention deficit hyperactivity disorder (ADHD). Whether this increased risk continues into adulthood is unknown. The authors assessed behavioral symptoms of ADHD in a well-characterized cohort of very-low-birth-weight young adults who were either small for gestational age (less than two standard deviations below the Finnish mean) or appropriate for gestational age (within two standard deviations of the mean). A total of 162 very-low-birth-weight subjects (small for gestational age: N=52; appropriate for gestational age: N=110) and 172 term comparison subjects 18 to 27 years of age completed the Adult Problem Questionnaire, which yielded six exploratory factor analysis-derived subscales. Participants were also asked about substance use. Very-low-birth-weight adults in the small for gestational age subgroup scored higher on the executive dysfunctioning and emotional instability subscales of the Adult Problem Questionnaire than did those in the appropriate for gestational age subgroup and the comparison group. The appropriate for gestational age and comparison groups had similar scores on these subscales. On the alcohol use subscale of the Adult Problem Questionnaire, both the appropriate and small for gestational age subgroups scored lower than comparison subjects and also reported fewer risk-taking behaviors (alcohol, smoking, and use of recreational drugs) than did comparison subjects. Rather than very low birth weight per se, intrauterine growth retardation, as reflected by small for gestational age status in the very-low-birth-weight subjects, confers a risk for behavioral and emotional adversity related to ADHD in young adulthood.